H3B-6527

H3B-6527 · H3 Biomedicine Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for H3B-6527, covering 2023-11-13 to 2023-11-13. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of H3B-6527 in Participants With Advanced Hepatocellular Carcinoma [Phase 1]

See pricing